Leading Global Multiple Sclerosis Research Center Taps IBM Analytics to Improve Patient Care

Stuart SchlossmanMS Research Study and Reports


Insights From Big Data Aimed At Slowing Progression of Multiple Sclerosis

By IBM
Published: Thursday, Apr. 26, 2012 – 6:12 am
ARMONK, N.Y., April 26, 2012 —/PRNewswire/ — IBM (NYSE: IBM) today announced that researchers from The State University of New York (SUNY) at Buffalo are using IBM analytics technology to study more than 2,000 genetic and environmental factors that may contribute to multiple sclerosis (MS) symptoms.
As part of the initiative, Researchers will tap into IBM’s analytics technology to develop algorithms for big data containing genomic datasets to uncover critical factors that speed up disease progression in MS patients.  Insights gained from the research will be shared with hundreds of doctors to better tailor individual treatments to slow brain injury, physical disability and cognitive impairments caused by MS.
Using IBM analytics technology, SUNY Buffalo researchers can for the first time explore clinical and patient data to find hidden trends among MS patients by looking at factors such as gender, geography, ethnicity, diet, exercise, sun exposure, and living and working conditions. The big data including medical records, lab results, MRI scans and patient surveys, arrives in various formats and sizes, requiring researchers to spend days making it manageable before they can analyze it.  
Using an IBM Netezza analytics appliance with software from IBM business partner, Revolution Analytics, researchers can now analyze all the disparate data in a matter of minutes instead of days, regardless of what type or size it is. The technology automatically consumes and analyzes the data, and makes the results available for further analysis. As a result, researchers can now focus their time on analyzing trends instead of managing data.
MS is a chronic neurological disease for which there is no cure. The disease is believed to be caused by a combination of genetic, environmental, infectious and autoimmune factors making treatment difficult. According to the National Multiple Sclerosis Society, there are approximately 400,000 people in the US with MS, and 200 people are diagnosed every week. Worldwide, MS is estimated to affect more than 2.1 million people.
“Multiple Sclerosis is a debilitating and complex disease whose cause is unknown. No two people share the exact same symptoms, and individual symptoms can worsen unexpectedly,” said Dr. Murali Ramanathan, Lead Researcher at SUNY Buffalo. “Identifying common trends across massive amounts of MS data is a monumental task that is much like trying to shoot a speeding bullet out of the sky with another bullet. IBM analytics helps our researchers fine tune their aim and match the speed of analysis with the rate of data coming into our systems. Our goal is to demystify why the disease progresses more rapidly in some patients and get those insights back to other researchers, so they can find new treatments.”

Read more here: http://www.sacbee.com/2012/04/26/4444458/leading-global-multiple-sclerosis.html#storylink=cpy


Read more here: http://www.sacbee.com/2012/04/26/4444458/leading-global-multiple-sclerosis.html#storylink=cpy

..
Comments are appreciated. Note that All comments are moderated 
 If not yet receiving our weekly e-Newsletter – Click here to: REGISTER 
so that you can be kept up to date with MS News and Information
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
LIKE this BLOG? – Please click the LIKE button top left

…………………………
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews